Editorial Board for section 'Molecular Cancer Biology'
- Molecular Cancer Biology Section
- Cancer Immunology and Immunotherapy Section
- Cancer Biomarkers Section
- Cancer Epidemiology and Prevention Section
- Cancer Pathophysiology Section
- Tumor Microenvironment Section
- Cancer Causes, Screening and Diagnosis Section
- Cancer Survivorship and Quality of Life Section
- Cancer Therapy Section
- Clinical Research of Cancer Section
- Systematic Review or Meta-Analysis in Cancer Research Section
- Methods and Technologies Development Section
- Cancer Informatics and Big Data Section
- Pediatric Oncology Section
- Infectious Agents and Cancer Section
- Cancer Drug Development Section
- Cancer Metastasis Section
- Transplant Oncology Section
Please see the section webpage for more information on this section.
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Interests: kidney cancer; bladder cancer; urothelial cancer; biomarker; prognosis; personalised medicine; urology; clinical trials
Interests: cancer; cell signaling; epigenetics; tissue homeostasis; therapeutic response
Special Issues, Collections and Topics in MDPI journals
Interests: microRNAs; lncRNAs; non-coding RNAs; circRNAs; B-cell lymphoma
Section Board Member
Interests: 3D nuclear structure; telomere/shelterin dysfunction; Reed-Sternberg cell; Hodgkin’s lymphoma; EBV; LMP1 oncogene
Special Issues, Collections and Topics in MDPI journals
Interests: prostate cancer; cervical cancer; breast cancer; colon cancer; transcriptional regulation; cancer metabolism; epithelial mesenchymal transition; microvesicles; tumor microenvironment
Interests: ccRCC; NGS; TSGs; LUAD driver mutations; microRNAs; intratumor heterogeneity
Special Issues, Collections and Topics in MDPI journals
2. Molecular Cancer Biology & Senescence Labortaory, Biomedical Research Institute (BRI), Foundation for Research and Technology (FORTH), Ioannina, Greece
Interests: cancer; senescence; DNA damage; inflammation; epithelial-to-mesenchymal cell transition; cell signalling; NF-kappaB; transcriptional regulation; epigenetics; miRNA
Interests: tumor immune evasion; STAT3; TLR9
Interests: clinical cancer genomics computation and analyses
Interests: drug development; drug resistance; cancer stem cells; glioma; pancreatic cancer
Interests: tumor microenvironment; cancer stem cells; tumor cell invasion; cell death; glioblastoma
Interests: head and neck cancer; cell cycle; ubiquitin-proteasome pathway; invasion; metastasis; oral pathology
Special Issues, Collections and Topics in MDPI journals
2. Department of Surgery and Cancer, Imperial College London, Du Cane Road, London W12 0NN, UK
Interests: Wnt signaling; TGF-beta signaling; prostate cancer; cancer stem cells; Dickkopf-3
Special Issues, Collections and Topics in MDPI journals
2. Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Ole Maaloes Vej 5, 2200 Copenhagen, Denmark
Interests: cancer biology; growth regulation and cell kinetics; invasion; chronobiology and clock gene aberrations in cancer; brain, urinary bladder and gastrointestinal cancer
Interests: apoptosis; necroptosis; inflammation; TNF; RIPK1; NF-κB; IAPs; Smac-mimetic
Interests: glioma; glioblastoma; malignant glioma; novel therapies
Special Issues, Collections and Topics in MDPI journals
Interests: colon cancer; drug resistance; biomarkers; cancer metabolism; personalized therapy
Interests: integrins; prostate cancer; extracellular vesicles; metastasis; growth factor receptors
2. Departamento de Bioquímica Médica y Biología Molecular e Inmunología, Facultad de Medicina, Universidad de Sevilla, 41009 Seville, Spain
Interests: cancer immunology; immunotherapy; melatonin; multiple sclerosis immunopathology
Special Issues, Collections and Topics in MDPI journals
2. Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD, USA
Interests: brain cancer; receptor tyrosine kinases; cell signaling; cancer stem cells; pre-clinical therapeutics
Interests: follicular lymphoma; mulitple myeloma; genomics; transcriptomics; receptor tyrosin kinase signaling; molecular biology; high-throughput-technologies (e.g., next generation sequencing, microarrays)
Interests: targeted agents in endometrial and ovarian cancer; hormonal therapy for endometrial cancer and the impact of mutations in TP53 on drug response
Special Issues, Collections and Topics in MDPI journals
2. Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA
3. Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA
4. Section of Urology, Department of Surgery, University of Nebraska Medical Center, Omaha, NE, USA
Interests: crosstalk of tyrosine phosphorylation, redox signaling and steroid hormone action in cell growth regulation and carcinogenesis; prostate cancer; molecular oncogenesis; tyrosine phosphorylation and dephosphorylation; redox signaling; steroid hormone action; translational research
Interests: ubiquitin-proteasome system; multiple myeloma; anti-tumor
Interests: glioblastoma; glioma; ribosome biogenesis; nucleolus; p53; DNA damage response in cancer
Special Issues, Collections and Topics in MDPI journals
Interests: innate immunity; tumor immunology; cancer immunotherapy; chaperone biology; unfolded protein response
Interests: hepatobiliary and pancreatic tumors
Special Issues, Collections and Topics in MDPI journals
2. Vall d'Hebron Research Institute (VHIR), 08035 Barcelona, Spain
Interests: protein kinases; cell signaling; cancer; anticancer drugs
Special Issues, Collections and Topics in MDPI journals
Interests: tumor growth; angiogenesis; metastasis; cancer cell signaling; mechanisms for drug resistance
Special Issues, Collections and Topics in MDPI journals
Interests: oral cancer; cancer stem cell; biomarkers; protein function; protein bioinformatics; protein–protein interactions; structure bioinformatics; cancer pharmaco-omics modelling; biomarker discovery; precision oncology; chemoinformatics; drug discovery informatics; virtual screening
Special Issues, Collections and Topics in MDPI journals